On March 25, 2022, Carl Sandler provided notice of his resignation as a member of the Board of Directors of Enochian Biosciences Inc. to focus on his other business ventures, with such resignation being effective March 25, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.45 USD | -8.81% | +1.40% | -54.26% |
Jun. 14 | Renovaro Says Investors Commit $10 Million Additional Equity | MT |
May. 24 | Renovaro, Amsterdam UMC Cancer Center Plan to Form Joint Venture for Cancer Immunotherapy | MT |
1st Jan change | Capi. | |
---|---|---|
-54.26% | 214M | |
+14.84% | 121B | |
+18.31% | 112B | |
+4.37% | 22.57B | |
-18.26% | 20.82B | |
-14.23% | 16.3B | |
-17.26% | 16.19B | |
-42.36% | 16.17B | |
-0.68% | 13.17B | |
+21.87% | 11.11B |
- Stock Market
- Equities
- RENB Stock
- News Renovaro Inc.
- Enochian Biosciences, Inc. Announces Resignation of Carl Sandler as Member of the Board of Directors